Financhill
Back

Myriad Genetics Stock Predictions

Myriad Genetics Stock Forecast

  • Is Myriad Genetics Stock Undervalued?
    The current Myriad Genetics [MYGN] share price is $4.11. The Score for MYGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • MYGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Myriad Genetics Stock Go Up Next Year?

Data Unavailable

Myriad Genetics Stock Rating

Data Unavailable

Myriad Genetics Stock Price History

Is MYGN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
myriad.com

52-Week Data

52-Week High:
29.30
52-Week Low:
3.83

Prediction Charts

Market Cap:
378.8M
Price in USD:
4.11
Volume:
3.6M
Beta:
1.13

Technical Analysis

SMA50:
8.27
SMA100:
10.76
SMA200:
17.07
52-Wk Change:
-83.51%

Stock Predictions

  • Is Myriad Genetics stock public?
    Yes, Myriad Genetics is a publicly traded company.
  • What is the Myriad Genetics stock quote today?
    The Myriad Genetics stock price is 4.11 USD today.
  • How to buy Myriad Genetics stock online?
    You can buy Myriad Genetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 7.37 7.37 7.46 7.22
Apr-25 7.31 7.42 7.43 7.16
Apr-28 7.44 7.50 7.71 7.30
Apr-29 7.49 7.20 7.56 7.17
Apr-30 7.16 7.41 7.55 7.11
May-1 7.44 7.13 7.48 6.94
May-2 7.27 7.56 7.66 7.21
May-5 7.55 7.70 7.78 7.36
May-6 7.65 7.27 7.81 7.24
May-7 5.70 4.27 5.82 4.24
May-8 4.29 4.03 4.31 3.98
May-9 4.09 3.89 4.23 3.86
May-12 4.00 4.25 4.26 3.83
May-13 4.25 4.11 4.31 4.08

Myriad Genetics Earnings

Data Unavailable

Myriad Genetics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.14 per share, and an increase next year of $0.19 per share.

* Myriad Genetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.